Parkinson's disease in populations of african origin a review

Neuroepidemiology

Volumn 15, Issue 4, 1996, Pages 214-221

  Richards, M ^a   Chaudhuri, Ray ^b  

^a Departments of Psychiatry   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Black African; Black American; Parkinson's disease

Indexed keywords

AFRICA; ARTICLE; CASE FINDING; HUMAN; MORTALITY; NEGRO; PARKINSON DISEASE; POPULATION RESEARCH; PREVALENCE; RACE DIFFERENCE; RISK FACTOR;

EID: 8944253776     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109910     Document Type: Article

References (52)

1. Zhang Z-X, Roman GC: Worldwide occurrence of Parkinson’s disease: An updated review. Neuroepidemiology 1993;12:195-208.
2. Muwazi EMK, Trowcll MC: Neurological diseases among African natives of Uganda: A review of 269 cases. East Afr Med J 1944;21:2.
3. Dada TO, Johnson FA, Araba AB, Adegbite SA: Cerebrovascular accidents in Nigeria-A review of 205 cases. West Afr Med J 1969; 18:95-108.
4. Collomb H, Dumas M, Girard PL: Neurological disorders in Senegal; in Spillane JD (ed): Tropical Neurology. London, Oxford University Press. 1973, pp 133-142.
5. Haddock DRW; Neurological disorders in Ghana; in Spillane JD (ed): Tropical Neurology. London, Oxford University Press, 1973, pp 143-160.
6. Osuntokun BO: Neurological disorders in Nigeria; in Spillane JD (ed): Tropical Neurology. London, Oxford University Press, 1973, pp 161-190.
7. Harries JR: Neurological disorders in Kenya; in Spillane JD (ed): Tropical Neurology. London, Oxford University Press, 1973, pp207-222.
8. Rachman I: Neurological disorders in Rhodesia; in Spillane JD (ed): Tropical Neurology. London, Oxford University Press, pp 237-246.
9. Osuntokun BO, Badcmosi O: Parkinsonism in the African. East Afr Med J 1979;56:597-607.
10. Ashok PP, Radhakrishnan K, Srid-haran R, Mousa ME: Epidemiology of Parkinson’s disease in Benghazi, North-East Libya. Clin Neurol Neu-rosurg 1986;88:109-113.
11. Osuntokun BO, Adeuja AOG, Schoenberg BS. Badcmosi O, Not-tidge VA, Olumide AO, Ige O, Yaria F, Bolis CL: Neurological disorders in Nigerian Africans: A community-based study. Acta Neurol Scand 1987;75:13-21.
12. Kessler II: Epidemiological studies of Parkinson’s disease. 111. A community-based survey. Am J Epidemiol 1972;96:242-254.
13. Paddison RM, Parker Grifith R: Occurrence of Parkinson’s disease in black patients at Charity Hospital in New Orleans. Neurology 1974,24: 688-690.
14. Lombard A, Gclfand M: Parkinson’s disease in the African. Cent Afr J Med 1978;24:5-8.
15. Schoenberg BS, Anderson DW, Haerer AF: Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
16. Mayeux R, Marder K, Cote LJ, Den-aro J, Hemenegildo N, Mejia H, Tang M, Lantigua R, Hauser A, Wilder D, Gurland B: The frequency of idiopathic Parkinson’s disease among middle-aged and elderly black, Hispanic and white men and women in Northern Manhattan (1988-1993). Am J Epidemiol, in press.
17. Haddock DRW: Neurological disorders in Tanzania. J Trop Med Hyg 1965:63:161.
18. Kessler II: Epidemiologic studies of Parkinson’s disease. II. A hospital-based survey. Am J Epidemiol 1972; 95:308-318.
19. Schoenberg BS, Osuntokun BO, Adeuja AOG, Badcmosi O, Nottidge V, Anderson DW, Haerer AF: Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies. Neurology 1988,38:645-646.
20. Chandra V, Bharucha NE, Schoenberg BS: Mortality data for the US for deaths due to and related to twenty neurologic diseases. Neuro-epidemiology 1984;3:149-168.
21. Kutzke JF, Goldberg MPH: Parkinsonism death rates by race, sex, and geography. Neurology 1988;38: 1558-1561.
22. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, Perl DP: Two decades of increasing mortality from Parkinson’s disease among the US elderly. Arch Neurol 1990;47:731-734.
23. Lilienfeld DE, Sekkor D, Simpson S, Perl DP, Ehland J, Marsh G, Chan E, Godbold JH, Landrigan PJ: Parkinsonism death rates by race, sex, and geography: A 1980s update. Neuroepidemiology 1990;9:243-247.
24. Lilienfeld DE, Perl DP: Projected ncurodcgencrativc disease mortality among minorities in the Unites States, 1990-2040. Neuroepidemiology 1994;13:179-186.
25. Kochanek K, Maurer M, Rosenberg H: Why did black life expectancy decline from 1984 through 1989 in the United States? Am J Public Health 1994;84:938-944.
26. Rajput AH: Environmental causation of Parkinson’s disease. Arch Neurol 1993;50:651-652.
27. Rajput AH, Uitti RJ, Stem W, Lav-erty W: Early onset Parkinson’s disease in Saskatchewan. Can J Neurol Sci 1986;13:213-216.
28. Rajput AH. Uitti RJ, Stem W, Lav-erty W. O’donnell K, O’donnell D, Yuen WK, Dua A: Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson’s disease. Can J Neurol Sci 1987;14:414-418.
29. Roller W, Vetere-Ovcrfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C: Environmental risk factors in Parkinson’s disease. Neurology 1990:40:1218-1221.
30. Tanner CM, Chen B, Wang W, Peng M. Liu Z, Lian X, Kao L, Gilley D, Schoenberg BS: Environmental risk factors in the etiology of Parkinson’s disease. Can J Neurol Sci 1987; 14:419-423.
31. Duvoisin R. Gearing I, Schweitzer MR, Yahr A: A family study of Parkinsonism; in Barbeau A, Brunette J (ed): Progress in Ncurogenetics. Amsterdam, Excerpta Medica Foundation, 1969, p 492.
32. Johnson WG, Hodge SE, Duvoisin R: Twin studies and the genetics of Parkinson’s disease-A reappraisal. Mov Disord 1990;5:187-194.
33. Maycux R. Tang M-X, Mardcr K, Cote L, Hauser A: Dietary iron as a potential antecedent factor in Parkinson’s disease. Ncurocpidemiolo-gy 1993;12:136-137.
34. Parker W, Boyson S, Parks J: Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723.
35. Schapira A, Cooper J, Dexter D, Jenner P, Clark JB, Marsden CD: Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1989; i: 1269.
36. Dykcn M, Wolf P, Barnett H. Ber-gan JJ. Hass WK, Kannel WB, Kull-cr L. Kurtzkc JF. Sundt TM: Risk factors in stroke: A statement for physicians for the Subcommittee on Risk Factors and Stroke of the Stroke Council. Stroke 1984; 15: 1105-1111.
37. NHLBI (National Heart, Lung and Blood Institute): Hypertension prevalence and the status of awareness, treatment and control in the United States. Hypertension 1985;7:457-468.
38. Grell GAC: Clinical aspects of the management of hypertension in the Caribbean. West Indian Med J 1980;20:163-174.
39. Chaturvedi N, McKeigue P, Marmot M: Resting and ambulatory blood pressure differences in Afro-Caribbcans and Europeans. Hypertension 1993;22:90-96.
40. American Heart Association: Heart and Stroke Factors: 1995 Statistical Supplement. Dallas, 1995.
41. Roseman JM: Diabetes in black Americans; in National Diabetes Data Group: Diabetes in America: Diabetes Data Compiled 1984. Washington, Government Printing Office, 1985, Vlll-I-Vlll (N1H Publication No. 85-1468).
42. Gaines K, Chcsney C. Vandcr Zwaag R, Cape C: Racial differences in coagulation studies in stroke. Neurol Res 1992;14:103-108.
43. Schreiner P: Lipoprotein (a) as a risk factor for prcclinical atherosclerotic disease in a biracia! cohort: The Atherosclerosis Risk in Communities (ARIC) Study. Chem Phys Lipids 1994:67-68:405-410.
44. Wilson TW, Hollifield LR, Grim CE: Systolic blood pressure levels in black populations in sub-Saharan Africa, the West Indies, and the United Stales: A meta-analysis. Hypertension 1991; 18, suppl 1:87-91.
45. Poulter NR, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Sever PS: The Kenyan Luo migration study: Observations on the initiation of a rise in blood pressure. BMJ 1990;300:967-972.
46. Critchley M: Arteriosclerotic parkinsonism. Brain 1929;52:23-83.
47. Parkes JD, Marsden CD, Rees JE, Curzon G, Kantamancni BD, Knill-Jones R, Akabar A, Das S, Kataria M: Parkinson’s disease, cerebral arteriosclerosis, and senile dementia. QJM 1974;93:49-61.
48. Inzelberg R, Bornstein NM, Reider I, Korczyn AD: Basal ganglia infarcts and parkinsonism. Neuroepi-dcmiology 1994;13:108-112.
49. Eadie MJ, Sutherland JM: Arteriosclerosis in Parkinsonism. J Neurol Neurosurg Psychiatry 1964;27:237-240.
50. Struck LK, Rodnitzky RL, Dobson JK: Stroke and its modification in Parkinson’s disease. Stroke 1990;21: 1395-1399.
51. Levine R. Jones J. Bee N: Stroke and Parkinson's disease. Stroke 1992;23: 839-842.
52. Tolosa ES, Santamaria J: Parkinsonism and basal ganglia infarcts. Neurology 1984;34:1516-1518.